688656 Stock Overview
HOB Biotech Group Corp.,Ltd. operates as a in vitro diagnostic company in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
HOB Biotech Group Corp.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥24.96 |
| 52 Week High | CN¥41.58 |
| 52 Week Low | CN¥17.93 |
| Beta | 0 |
| 1 Month Change | -4.84% |
| 3 Month Change | -0.20% |
| 1 Year Change | -29.21% |
| 3 Year Change | -68.22% |
| 5 Year Change | n/a |
| Change since IPO | -61.00% |
Recent News & Updates
Shareholder Returns
| 688656 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 7.6% | 3.5% | 4.4% |
| 1Y | -29.2% | -22.5% | -12.6% |
Return vs Industry: 688656 underperformed the CN Biotechs industry which returned -22.5% over the past year.
Return vs Market: 688656 underperformed the CN Market which returned -12.6% over the past year.
Price Volatility
| 688656 volatility | |
|---|---|
| 688656 Average Weekly Movement | 11.0% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 688656 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688656's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 493 | John Li | www.hobiotech.com |
HOB Biotech Group Corp.,Ltd. operates as a in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immuno assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.
HOB Biotech Group Corp.,Ltd Fundamentals Summary
| 688656 fundamental statistics | |
|---|---|
| Market cap | CN¥1.60b |
| Earnings (TTM) | CN¥45.58m |
| Revenue (TTM) | CN¥399.23m |
34.5x
P/E Ratio3.9x
P/S RatioIs 688656 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688656 income statement (TTM) | |
|---|---|
| Revenue | CN¥399.23m |
| Cost of Revenue | CN¥147.43m |
| Gross Profit | CN¥251.80m |
| Other Expenses | CN¥206.22m |
| Earnings | CN¥45.58m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.72 |
| Gross Margin | 63.07% |
| Net Profit Margin | 11.42% |
| Debt/Equity Ratio | 10.2% |
How did 688656 perform over the long term?
See historical performance and comparison